Johannes Nippgen
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 1%
- Pathology and Forensic Medicine top 1%
- Hepatology top 1%
- Molecular Biology top 10%
- Co-authors
- Eric Van CutsemChristopher StrohPhilippe RougierJ. ZałuskiGeert D’HaensTamás PintérSabine TejparRobert Lim
- Topics
- Colorectal Cancer Treatments and Studies (12 papers)Lung Cancer Treatments and Mutations (12 papers)Cancer Treatment and Pharmacology (5 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Johannes Nippgen
27 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Oncology 3.2k
- Pulmonary and Respiratory Medicine 1.4k
- Pathology and Forensic Medicine 922
- Hepatology 898
- Molecular Biology 782
Countries citing papers authored by Johannes Nippgen
This map shows the geographic impact of Johannes Nippgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Nippgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Nippgen more than expected).
Fields of papers citing papers by Johannes Nippgen
This network shows the impact of papers produced by Johannes Nippgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Nippgen. The network helps show where Johannes Nippgen may publish in the future.
Co-authorship network of co-authors of Johannes Nippgen
This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Nippgen. A scholar is included among the top collaborators of Johannes Nippgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Nippgen. Johannes Nippgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 10 | |
| 3 | 1 | |
| 4 | 44 | |
| 5 | 50 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancerbreakdown → | 2902 |
| 9 | 41 | |
| 10 | The EVEREST study: relationship between efficacy and K-RAS mutation status in patients with irinotecan-refactory MCRC treated with irinotecan and standard or escalating doses of cetuximab | 4 |
| 11 | Relationship of efficacy with kras status (wild type [wt] vs mutant [mt]) in patients with irinotecan-refractory metastatic colorectal cancer (mcrc), treated with irinotecan and escalating doses of cetuximab: preliminary data from the everest study | 1 |
| 12 | 93 | |
| 13 | 181 | |
| 14 | 377 | |
| 15 | 233 | |
| 16 | 37 | |
| 17 | Mature results of a phase I/IIA trial of the integrin inhibitor cilengitide (EMD121974) added to standard concomitant and adjuvant temozolomide and radiotherapy (TMZ/RT) for newly diagnosed glioblastoma (GBM) | 10 |
| 18 | 72 | |
| 19 | 26 | |
| 20 | 14 |
About Johannes Nippgen
Johannes Nippgen is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 4.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Lung Cancer Treatments and Mutations (12 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Oncology (3.2k citations), Hepatology (898 citations) and Pathology and Forensic Medicine (922 citations). Johannes Nippgen has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Eric Van Cutsem, Christopher Stroh, Philippe Rougier, J. Załuski, Geert D’Haens, Tamás Pintér, Sabine Tejpar, Robert Lim, Anatoly Makhson and Gunnar Folprecht. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.